ReproNAGEN
Study of genetic causes of infertility, prevention of serious diseases in offspring, and support for therapeutic management decisions.
Learn moreProjects of the NAGEN programme
The NAGEN Programme includes strategic projects that have incorporated genomics into clinical practice: NAGEN1000, PharmaNAGEN, NAGENCOL, NAGENpediatrics, NAGEN-MX and ReproNAGEN. Their common goal is to integrate genomic data with clinical information to improve diagnosis and management, basis for which NAGENdata enables the secure reuse of genomes with clinical descriptions.
NAGEN-MX
A nationally pioneering, personalized, and stratified population-based screening program for the early detection of breast cancer, based on whole genome sequencing.
Learn moreNAGEN1000
Implementation of clinical whole-genome sequencing to improve the diagnosis of rare diseases in the SNS-O and establish protocols for patient identification and results management.
Learn moreNAGENpedriatics
Use of whole genome sequencing in acute pediatric settings with a high genetic suspicion to accelerate diagnosis and therapy; this includes local deployment for analysis and interpretation.
Learn moreNAGENCOL
Personalizing hypercholesterolemia management through WGS data and conventional clinical variables (risk stratification and therapeutic decisions).
Learn morepharmaNAGEN
Clinical application of pharmacogenomics for safer, more effective, and cost-efficient pharmacotherapy for the population of Navarra.
Learn more